Conmed Names Gallagher, Succeeding Garner

Dow Jones
06/18

By Grace Yoon

Conmed appointed John Gallagher as chief financial officer, effective July 15.

Gallagher will succeed Todd Garner, who will remain with the medical technology company as an adviser through November 2.

Gallagher has three decades of financial experience, most recently serving as CFO of Certara, a pharmaceutical technology company. Prior to Certara, he was CFO of Cue Health and held other finance roles at Becton Dickinson, the Conmed said Wednesday.

Certara on Wednesday said that Gallagher was resigning, effective July 14.

Write to Grace Yoon at grace.yoon@wsj.com

 

(MORE TO FOLLOW) Dow Jones Newswires

June 17, 2026 16:59 ET (20:59 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10